评估圆锥角膜自然进展与年龄、性别和疾病严重程度的关系。

IF 2.1 3区 医学 Q2 OPHTHALMOLOGY
Onur Ozalp, Mustafa Kemal Ozaslan, Fatih Apaydin, Metehan Karaatli, Betin Bilkan Karaman, Nilgün Yildirim, Cezmi Dogan, Eray Atalay
{"title":"评估圆锥角膜自然进展与年龄、性别和疾病严重程度的关系。","authors":"Onur Ozalp, Mustafa Kemal Ozaslan, Fatih Apaydin, Metehan Karaatli, Betin Bilkan Karaman, Nilgün Yildirim, Cezmi Dogan, Eray Atalay","doi":"10.1097/ICO.0000000000003979","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the natural progression of keratoconus (KC) with respect to age, gender, and disease severity at presentation.</p><p><strong>Methods: </strong>This study analyzed 949 eyes from 503 patients with KC followed at Eskişehir Osmangazi University and Istanbul University-Cerrahpaşa between 2009 and 2023. Patients with ≥1 year of follow-up with ≥3 Pentacam (Oculus, Inc) scans spaced ≥3 months apart were eligible. Progression was identified using Belin ABCD Progression Display using 2 baseline visits. Progression rates were analyzed according to age groups (≤18, >18 to ≤24, >24 to ≤30, >30 to <35, and ≥35 years), and KC severity was categorized based on the Topographic Keratoconus Classification (TKC) as subclinical, early-stage (TKC 1-2) and advanced-stage (TKC 3-4). Median time-to-progression (M-TTP) for progressive eyes was calculated with reference to the first presentation.</p><p><strong>Results: </strong>Keratoconus progression rates declined significantly with age (P < 0.001); however, 44.3% of patients aged ≥35 years still showed progression, with the highest rate in those ≤18 years (86.4%). In patients ≥35 years, advanced-stage disease (TKC 3 and 4) markedly increased progression risk (OR: 10.5 [P = 0.03], 20.0 [P = 0.008], respectively). The shortest time-to-progression occurred in patients aged ≤18 years (M-TTP: 8.6 and 5.8 months in TKC 1-2 and 3-4, respectively), whereas in those ≥35 years, advanced-stage disease progressed significantly earlier than early-stage (M-TTP: 18.9 vs. 38.2 months).</p><p><strong>Conclusions: </strong>Although progression typically slows with age, 44% of patients ≥35 years still progressed. The shorter time-to-progression in younger individuals and in older patients with advanced disease at presentation highlight the need for close monitoring in both groups.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluating Natural Progression of Keratoconus in Relation to Age, Gender, and Disease Severity at Presentation.\",\"authors\":\"Onur Ozalp, Mustafa Kemal Ozaslan, Fatih Apaydin, Metehan Karaatli, Betin Bilkan Karaman, Nilgün Yildirim, Cezmi Dogan, Eray Atalay\",\"doi\":\"10.1097/ICO.0000000000003979\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To investigate the natural progression of keratoconus (KC) with respect to age, gender, and disease severity at presentation.</p><p><strong>Methods: </strong>This study analyzed 949 eyes from 503 patients with KC followed at Eskişehir Osmangazi University and Istanbul University-Cerrahpaşa between 2009 and 2023. Patients with ≥1 year of follow-up with ≥3 Pentacam (Oculus, Inc) scans spaced ≥3 months apart were eligible. Progression was identified using Belin ABCD Progression Display using 2 baseline visits. Progression rates were analyzed according to age groups (≤18, >18 to ≤24, >24 to ≤30, >30 to <35, and ≥35 years), and KC severity was categorized based on the Topographic Keratoconus Classification (TKC) as subclinical, early-stage (TKC 1-2) and advanced-stage (TKC 3-4). Median time-to-progression (M-TTP) for progressive eyes was calculated with reference to the first presentation.</p><p><strong>Results: </strong>Keratoconus progression rates declined significantly with age (P < 0.001); however, 44.3% of patients aged ≥35 years still showed progression, with the highest rate in those ≤18 years (86.4%). In patients ≥35 years, advanced-stage disease (TKC 3 and 4) markedly increased progression risk (OR: 10.5 [P = 0.03], 20.0 [P = 0.008], respectively). The shortest time-to-progression occurred in patients aged ≤18 years (M-TTP: 8.6 and 5.8 months in TKC 1-2 and 3-4, respectively), whereas in those ≥35 years, advanced-stage disease progressed significantly earlier than early-stage (M-TTP: 18.9 vs. 38.2 months).</p><p><strong>Conclusions: </strong>Although progression typically slows with age, 44% of patients ≥35 years still progressed. The shorter time-to-progression in younger individuals and in older patients with advanced disease at presentation highlight the need for close monitoring in both groups.</p>\",\"PeriodicalId\":10710,\"journal\":{\"name\":\"Cornea\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cornea\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/ICO.0000000000003979\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cornea","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ICO.0000000000003979","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨圆锥角膜(KC)的自然进展与年龄、性别和疾病严重程度的关系。方法:本研究分析了2009年至2023年在eskiehir Osmangazi大学和伊斯坦布尔大学- cerrahpa随访的503例KC患者的949只眼睛。随访≥1年,间隔≥3个月进行≥3次Pentacam (Oculus, Inc)扫描的患者符合条件。通过2次基线就诊,使用Belin ABCD进展显示来确定病情进展。按年龄分组(≤18岁,>8 ~≤24岁,>24 ~≤30岁,>30 ~)分析进展率。结果:圆锥角膜进展率随年龄的增长而显著下降(P < 0.001);然而,≥35岁的患者中仍有44.3%出现进展,其中≤18岁的患者比例最高(86.4%)。在≥35岁的患者中,晚期疾病(TKC 3和4)显著增加进展风险(OR分别为10.5 [P = 0.03]和20.0 [P = 0.008])。最短的进展时间发生在≤18岁的患者(TKC 1-2和3-4中M-TTP分别为8.6和5.8个月),而≥35岁的患者,晚期疾病进展明显早于早期(M-TTP: 18.9和38.2个月)。结论:尽管进展通常随着年龄的增长而减慢,但44%≥35岁的患者仍有进展。年轻个体和老年晚期患者的进展时间较短,这两组患者都需要密切监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluating Natural Progression of Keratoconus in Relation to Age, Gender, and Disease Severity at Presentation.

Purpose: To investigate the natural progression of keratoconus (KC) with respect to age, gender, and disease severity at presentation.

Methods: This study analyzed 949 eyes from 503 patients with KC followed at Eskişehir Osmangazi University and Istanbul University-Cerrahpaşa between 2009 and 2023. Patients with ≥1 year of follow-up with ≥3 Pentacam (Oculus, Inc) scans spaced ≥3 months apart were eligible. Progression was identified using Belin ABCD Progression Display using 2 baseline visits. Progression rates were analyzed according to age groups (≤18, >18 to ≤24, >24 to ≤30, >30 to <35, and ≥35 years), and KC severity was categorized based on the Topographic Keratoconus Classification (TKC) as subclinical, early-stage (TKC 1-2) and advanced-stage (TKC 3-4). Median time-to-progression (M-TTP) for progressive eyes was calculated with reference to the first presentation.

Results: Keratoconus progression rates declined significantly with age (P < 0.001); however, 44.3% of patients aged ≥35 years still showed progression, with the highest rate in those ≤18 years (86.4%). In patients ≥35 years, advanced-stage disease (TKC 3 and 4) markedly increased progression risk (OR: 10.5 [P = 0.03], 20.0 [P = 0.008], respectively). The shortest time-to-progression occurred in patients aged ≤18 years (M-TTP: 8.6 and 5.8 months in TKC 1-2 and 3-4, respectively), whereas in those ≥35 years, advanced-stage disease progressed significantly earlier than early-stage (M-TTP: 18.9 vs. 38.2 months).

Conclusions: Although progression typically slows with age, 44% of patients ≥35 years still progressed. The shorter time-to-progression in younger individuals and in older patients with advanced disease at presentation highlight the need for close monitoring in both groups.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cornea
Cornea 医学-眼科学
CiteScore
5.20
自引率
10.70%
发文量
354
审稿时长
3-6 weeks
期刊介绍: For corneal specialists and for all general ophthalmologists with an interest in this exciting subspecialty, Cornea brings together the latest clinical and basic research on the cornea and the anterior segment of the eye. Each volume is peer-reviewed by Cornea''s board of world-renowned experts and fully indexed in archival format. Your subscription brings you the latest developments in your field and a growing library of valuable professional references. Sponsored by The Cornea Society which was founded as the Castroviejo Cornea Society in 1975.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信